May 2 (Reuters) - Koninklijke DSM NV DSMN.AS :
* Q1 SALES EUR 1.89 BILLION VERSUS EUR 2.01 BILLION YEAR AGO
* Q1 ADJUSTED EBITDA EUR 278 MILLION VERSUS EUR 367 MILLION
YEAR
AGO
* IT IS INTENDED THAT DSM-FIRMENICH WILL PROVIDE AN OUTLOOK
FOR
REMAINDER OF 2023 AT PUBLICATION OF ITS HALF YEAR RESULTS ON 2
AUGUST 2023
* AS OF 28 APRIL 2023, DSM-FIRMENICH AG HOLDS 96.1% OF
ORDINARY
SHARES IN DSM N.V.
* ON 8 MAY 2023, FIRMENICH INTERNATIONAL SA WILL BECOME PART
OF
DSM-FIRMENICH AG THROUGH FIRMENICH CONTRIBUTION
* WE ANTICIPATE A STRONGER SECOND HALF OF YEAR ACROSS ALL
BUSINESSES
* WE DO NOT FORESEE A SIGNIFICANT IMPROVEMENT IN THESE
CONDITIONS
(HIGH RATE OF GLOBAL INFLATION, LOW VITAMIN PRICES) IN Q2
Source text for Eikon: ID:nPrenk0L9a
Further company coverage: DSMN.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))